Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. S3A-376 Study Group.

Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. S3A-376 Study Group. Cancer Invest. 1997; 15(4):297-303.

View in: PubMed

subject areas

Administration, Oral
Adult
Aged
Aged, 80 and over
Antiemetics
Antineoplastic Combined Chemotherapy Protocols
Appetite
Cyclophosphamide
Double-Blind Method
Doxorubicin
Drug Administration Schedule
Female
Humans
Male
Methotrexate
Middle Aged
Nausea
Neoplasms
Ondansetron
Time Factors
Vomiting

authors with profiles

Rudolph Navari